Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
Published Fri, Jun 13, 2025 · 05:38 PM Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking ...
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiativesPublished Wed, May 7, 2025 · ...
EUROPE’S Stoxx 600 closed slightly higher at the start of a holiday-shortened week, as a spike in Novo Nordisk shares ...
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuanNovo Nordisk said on Monday ...
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of ...
Novo Nordisk Chief Executive Lars Fruergaard Jorgensen speaks to reporters at the companyÕs headquarters in Copenhagen, Denmark, February 5, 2020. ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.